Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,407,725
+$15,295,615 QoQ
Shares Held
27,853
+41.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#671
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANCOCK WHITNEY CORP holds $246,232,753 across 10 Drug Manufacturers - General names. LLY ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
218,107 | $55,392,634 | |
| 2 | AMGN |
Amgen Inc
|
143,155 | $51,839,288 | |
| 3 | MRK |
Merck & Co., Inc.
|
291,028 | $37,397,097 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
27,853 | $33,407,725 | |
| 5 | ABBV |
AbbVie Inc.
|
121,958 | $30,689,510 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
475,690 | $27,409,257 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
36,474 | $4,608,124 | |
| 8 | PFE |
Pfizer Inc
|
140,375 | $3,380,229 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,407,725 | 27,853 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,112,110 | 19,692 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,871,888 | 20,352 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,190,860 | 21,220 | Shares | Defined | 2025-11-17 | |
| 2025-06-30 | $26,843,894 | 34,436 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,879,535 | 28,913 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $22,448,216 | 29,078 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $36,935,723 | 41,691 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $37,558,782 | 41,484 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $27,619,134 | 35,502 | Shares | Other | 2024-05-16 | |
| 2023-12-31 | $20,758,946 | 35,612 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,812,031 | 29,438 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,922,138 | 29,686 | Shares | Other | 2023-11-13 | |
| 2023-03-31 | $5,844,664 | 17,019 | Shares | Other | 2023-11-13 | |
| 2022-12-31 | $6,730,723 | 18,398 | Shares | Other | 2023-11-13 | |
| 2022-09-30 | $5,994,908 | 18,540 | Shares | Other | 2022-10-26 | |
| 2022-06-30 | $6,180,794 | 19,063 | Shares | Other | 2022-08-08 | |
| 2022-03-31 | $5,583,068 | 19,496 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $5,560,584 | 20,131 | Shares | Other | 2022-01-25 | |
| 2021-09-30 | $4,616,609 | 19,981 | Shares | Other | 2021-11-04 | |
| 2021-06-30 | $3,554,346 | 15,486 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,852,553 | 15,269 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,972,428 | 17,605 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,643,932 | 17,862 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,981,344 | 18,159 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $4,521,716 | 32,596 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||